BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurzu S, Kobori L, Fodor D, Jung I. Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review. Biomed Res Int 2019;2019:2962580. [PMID: 31781608 DOI: 10.1155/2019/2962580] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Li K, Cao J, Zhang Z, Chen K, Ma T, Yang W, Yang S, Rao J, Zhang K. Circular RNA circGSK3B Promotes Cell Proliferation, Migration, and Invasion by Sponging miR-1265 and Regulating CAB39 Expression in Hepatocellular Carcinoma. Front Oncol 2020;10:598256. [PMID: 33262952 DOI: 10.3389/fonc.2020.598256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ding J, Li HY, Zhang L, Zhou Y, Wu J. Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma. Cells 2021;10:123. [PMID: 33440657 DOI: 10.3390/cells10010123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang C, Xiao Y, Du Y, Xiong J, Deng L, Liang Q, Yuan J, He C, He F, Huang X, Zhang Y. Iodine-125 Seeds Inhibit Carcinogenesis of Hepatocellular Carcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via TGF-β1/Smad Signaling. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/9230647] [Reference Citation Analysis]
4 Feng S, Zhang L, Liu X, Li G, Zhang B, Wang Z, Zhang H, Ma H. Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming. J Cell Mol Med 2020;24:7789-801. [PMID: 32519437 DOI: 10.1111/jcmm.15410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Marin JJG, Romero MR, Herraez E, Asensio M, Ortiz-Rivero S, Sanchez-Martin A, Fabris L, Briz O. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems. Semin Liver Dis 2021. [PMID: 34544160 DOI: 10.1055/s-0041-1735631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Busuioc C, Ciocan-Cartita CA, Braicu C, Zanoaga O, Raduly L, Trif M, Muresan MS, Ionescu C, Stefan C, Crivii C, Al Hajjar N, Mǎrgǎrit S, Berindan-Neagoe I. Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma. J Pers Med 2021;11:476. [PMID: 34073426 DOI: 10.3390/jpm11060476] [Reference Citation Analysis]
7 Kitamura H, Hashimoto M. USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes. Int J Mol Sci 2021;22:1209. [PMID: 33530560 DOI: 10.3390/ijms22031209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lim WC, Kim H, Kim YJ, Jeon BN, Kang HB, Ko H. Catechol inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition and stem cell-like properties in hepatocellular carcinoma cells. Sci Rep 2020;10:7620. [PMID: 32376896 DOI: 10.1038/s41598-020-64603-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Peng JL, Wu JZ, Li GJ, Wu JL, Xi YM, Li XQ, Wang L. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24172. [PMID: 33466191 DOI: 10.1097/MD.0000000000024172] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Liu L, Jiang H, Pan H, Zhu X. LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression. J Int Med Res 2021;49:3000605211016211. [PMID: 34018840 DOI: 10.1177/03000605211016211] [Reference Citation Analysis]
11 Wu S, Ye S, Lin X, Chen Y, Zhang Y, Jing Z, Liu W, Chen W, Lin X, Lin X. Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling. Cancer Lett 2021;499:175-87. [PMID: 33249195 DOI: 10.1016/j.canlet.2020.11.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Li JJ, Liang Q, Sun GC. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. J Integr Med 2021;19:469-77. [PMID: 34538644 DOI: 10.1016/j.joim.2021.08.004] [Reference Citation Analysis]
13 Matsushita K, Toyoda T, Yamada T, Morikawa T, Ogawa K. Specific expression of survivin, SOX9, and CD44 in renal tubules in adaptive and maladaptive repair processes after acute kidney injury in rats. J Appl Toxicol 2021;41:607-17. [PMID: 32969066 DOI: 10.1002/jat.4069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Xu D, Wang Y, Wu J, Lin S, Chen Y, Zheng J. Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma. Cancer Cell Int 2021;21:621. [PMID: 34819088 DOI: 10.1186/s12935-021-02326-8] [Reference Citation Analysis]
15 Li X, Liu Z, Wei X, Lin J, Yang Q, Xie Y. Comprehensive Analysis of the Expression and Clinical Significance of THO Complex Members in Hepatocellular Carcinoma. IJGM 2022;Volume 15:2695-713. [DOI: 10.2147/ijgm.s349925] [Reference Citation Analysis]
16 Franz L, Nicolè L, Frigo AC, Ottaviano G, Gaudioso P, Saccardo T, Visconti F, Cappellesso R, Blandamura S, Fassina A, Marioni G. Epithelial-to-Mesenchymal Transition and Neoangiogenesis in Laryngeal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3339. [PMID: 34283055 DOI: 10.3390/cancers13133339] [Reference Citation Analysis]
17 Zhao E, Chen S, Dang Y. Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma. Front Mol Biosci 2020;7:620765. [PMID: 33553243 DOI: 10.3389/fmolb.2020.620765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sun K, Zhang L, Chen P, Qi D, Liu H, Bao H, Wang X, Li T. Circular RNA circ SET domain containing 2 (circSETD2) inhibits hepatocellular carcinoma cell proliferation and invasion in vivo and in vitro. Bioengineered 2022;13:7293-302. [PMID: 35260047 DOI: 10.1080/21655979.2022.2048577] [Reference Citation Analysis]
19 Gurzu S, Burlacu D, Jung I, Raza F. Nonpolypous Hamartomas of the Gastrointestinal Tract: An Updated Review on Classification, Denominations, and Clinical Management. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/6983460] [Reference Citation Analysis]
20 Kubelac P, Braicu C, Raduly L, Chiroi P, Nutu A, Cojocneanu R, Budisan L, Berindan-Neagoe I, Achimas-Cadariu P. Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer. Diagnostics (Basel) 2021;11:344. [PMID: 33669647 DOI: 10.3390/diagnostics11020344] [Reference Citation Analysis]
21 Gao F, Zhang Y, Yang Z, Wang M, Zhou Z, Zhang W, Ren Y, Han X, Wei M, Sun Z, Nie S. Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis. Front Pharmacol 2020;11:584098. [PMID: 33390951 DOI: 10.3389/fphar.2020.584098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Xie YL, Yang Z, Feng X, Yang Q, Ye LS, Li XB, Tang H, Zhang YC, Liu W, Tong Zhang, Fu BS, Yi SH, Yang Y, Chen GH. Association of phenotypic transformation of circulating tumor cells and early recurrence in patients with hepatocellular carcinoma following liver transplantation. Asian J Surg 2021:S1015-9584(21)00477-2. [PMID: 34426060 DOI: 10.1016/j.asjsur.2021.07.058] [Reference Citation Analysis]
23 Bao L, Li P, Zhao H, Chen L, Wang Y, Liang S, Liu J. Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324-3p/GLYATL1 axis. Dig Liver Dis 2021:S1590-8658(21)00808-2. [PMID: 34782279 DOI: 10.1016/j.dld.2021.10.003] [Reference Citation Analysis]
24 Meng R, Cai WK, Xu WM, Feng Q, Wang P, Huang YH, Fan YX, Zhou T, Yang Q, Li ZR, He GH. Generation and identification of endothelial-specific Hrh2 knockout mice. Transgenic Res 2021;30:251-61. [PMID: 33786748 DOI: 10.1007/s11248-021-00244-z] [Reference Citation Analysis]
25 Satala CB, Jung I, Kobori L, Kovacs Z, Fodor D, Szodorai R, Gurzu S. Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging. J Gastrointest Cancer 2021;52:243-8. [PMID: 32173767 DOI: 10.1007/s12029-020-00394-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zhang S, Tian R, Bei C, Zhang H, Kong J, Zheng C, Song X, Li D, Tan H, Zhu X, Tan S. Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:5731-41. [PMID: 32606785 DOI: 10.2147/OTT.S250370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Wang H, Ramshekar A, Kunz E, Hartnett ME. 7-ketocholesterol induces endothelial-mesenchymal transition and promotes fibrosis: implications in neovascular age-related macular degeneration and treatment. Angiogenesis 2021;24:583-95. [PMID: 33646466 DOI: 10.1007/s10456-021-09770-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhang L, Zou L, Ma Y, Feng C, Zhan R, Yang H, Song B, Han Z. Multifaceted modifications for a cell size-based circulating tumor cell scope technique hold the prospect for large-scale application in general populations. Cell Biol Int. 2021;45:345-357. [PMID: 33085139 DOI: 10.1002/cbin.11491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zhang Y, Wang D, Zhu T, Yu J, Wu X, Lin W, Zhu M, Dai Y, Zhu J. CircPUM1 promotes hepatocellular carcinoma progression through the miR-1208/MAP3K2 axis. J Cell Mol Med 2021;25:600-12. [PMID: 33320435 DOI: 10.1111/jcmm.15998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Shen L, Gu P, Qiu C, Ding W, Zhang L, Cao W, Li Z, Yan B, Sun X. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100680] [Reference Citation Analysis]
31 Wu W, Shi X, Zhang F, Zhu K, Zhang R, Yu X, Qin Y, He S, Fu H, Zhang L, Zeng H, Zhu M, Xu L, Wong P, Liu C. Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis. Oncogene. [DOI: 10.1038/s41388-022-02246-5] [Reference Citation Analysis]
32 Gurzu S, Sugimura H, Szederjesi J, Szodorai R, Braicu C, Kobori L, Fodor D, Jung I. Interaction between cadherins, vimentin, and V-set and immunoglobulin domain containing 1 in gastric-type hepatocellular carcinoma. Histochem Cell Biol 2021. [PMID: 34170400 DOI: 10.1007/s00418-021-02006-8] [Reference Citation Analysis]
33 Wu D, Zhang R, Zhan L. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile. Clin Res Hepatol Gastroenterol 2021;46:101812. [PMID: 34597849 DOI: 10.1016/j.clinre.2021.101812] [Reference Citation Analysis]
34 Hong H, Jin Z, Qian T, Xu X, Zhu X, Fei Q, Yang J, Sui C, Xu M. Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma via Down-Regulating the STAT3-Modulated PTTG1 Pathway. Front Pharmacol 2021;12:656697. [PMID: 34025420 DOI: 10.3389/fphar.2021.656697] [Reference Citation Analysis]